DENTSPLY SIRONA Inc. (XRAY)
NASDAQ: XRAY · Real-Time Price · USD
16.57
-0.13 (-0.78%)
May 19, 2025, 10:25 AM - Market open
DENTSPLY SIRONA Revenue
DENTSPLY SIRONA had revenue of $879.00M in the quarter ending March 31, 2025, a decrease of -7.76%. This brings the company's revenue in the last twelve months to $3.72B, down -5.61% year-over-year. In the year 2024, DENTSPLY SIRONA had annual revenue of $3.79B, down -4.34%.
Revenue (ttm)
$3.72B
Revenue Growth
-5.61%
P/S Ratio
0.90
Revenue / Employee
$265,643
Employees
14,000
Market Cap
3.30B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.79B | -172.00M | -4.34% |
Dec 31, 2023 | 3.97B | 43.00M | 1.10% |
Dec 31, 2022 | 3.92B | -309.00M | -7.30% |
Dec 31, 2021 | 4.23B | 892.00M | 26.71% |
Dec 31, 2020 | 3.34B | -683.00M | -16.98% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
XRAY News
- 3 hours ago - Dentsply Sirona to Participate in the 2025 Stifel Jaws & Paws Conference - GlobeNewsWire
- 1 day ago - Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 4 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Shareholders to Inquire about Securities Investigation - Accesswire
- 6 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Shareholders to Connect - Accesswire
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Stockholders to Inquire about Securities Investigation - Accesswire
- 10 days ago - Dentsply Sirona Stock Is Rallying The Most Since 2019 on Thursday – What's Driving It? - Benzinga
- 11 days ago - DENTSPLY SIRONA Inc. (XRAY) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Investors to Learn More About the Investigation - Accesswire